Log in

1530 3SBio, Inc. HKEX · China

3SBio (1530) news

3SBio, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1530, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest 3SBio news

We have not published a story on 3SBio yet. When there is news, it will appear here.

Questions about 3SBio

What is the ticker symbol of 3SBio?

3SBio, Inc. trades under the ticker 1530 on HKEX.

Where is 3SBio listed?

3SBio, Inc. is listed on HKEX. Our directory also records these other listings: GETTEX:83B; OTC:TRSBF.

Which country or territory is 3SBio listed under?

Our directory records 3SBio, Inc. under China.

What does 3SBio do?

Our directory classifies 3SBio, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of 3SBio?

The ISIN recorded for 3SBio, Inc. is KYG8875G1029.

Does aibio.space cover 3SBio?

aibio.space lists 3SBio, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to 3SBio?

Companies in our directory listed in the same country and business area as 3SBio: Jiangxi Institute of Biological Products, Alphamab Oncology, Shanghai ZJ Bio-Tech Co., Hualan Biological Vaccine, Wuhan Keqian Biology Co., Wuhan Healthgen Biotechnology.

Investor discussion: 3SBio

Members talk about 3SBio (1530). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at 3SBio, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY, PROPOSED CHANGE OF AUDITOR AND NOTICE OF THE ANNUAL GENERAL MEETING. Source

  2. Financings

    Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  3. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source

  4. Financings

    Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  5. Financings

    Share or debt issue: (1) THE LICENSE AGREEMENT FOR PD-1/VEGF BISPECIFIC ANTIBODY (SSGJ-707) WITH PFIZER COMING INTO EFFECT; AND (2) PROPOSED SUBSCRIPTION OF NEW SHARES BY PFIZER UNDER GENERAL MANDATE. Source

  6. Financings

    Share or debt issue: GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY, ADOPTION OF THE 2025 SHARE OPTION SCHEME, ADOPTION OF THE 2025 SHARE AWARD SCHEME AND NOTICE OF THE ANNUAL GENERAL MEETING. Source

Press releases

Headlines of 3SBio's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. PR Newswire

    Median PFS Approaches 14 Months! 3SBio's PD-1/VEGF Bispecific Antibody Posts Impressive Data at ESMO 2026

  2. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  3. HKEXnews

    (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 JUNE 2026; (2) PAYMENT OF FINAL DIVIDEND; AND (3) CHANGE OF AUDITOR

  4. HKEXnews

    NOTICE OF THE ANNUAL GENERAL MEETING

  5. HKEXnews

    GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY, PROPOSED CHANGE OF AUDITOR AND NOTICE OF THE ANNUAL GENERAL MEETING

  6. HKEXnews

    PROPOSED CHANGE OF AUDITOR

  7. HKEXnews

    NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  8. HKEXnews

    NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  9. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 23 APRIL 2026

  10. HKEXnews

    NOTICE OF THE EXTRAORDINARY GENERAL MEETING

  11. HKEXnews

    CONDITIONAL SPECIAL DIVIDEND BY WAY OF DISTRIBUTION IN SPECIE AND NOTICE OF EXTRAORDINARY GENERAL MEETING

  12. HKEXnews

    PROPOSED SPIN-OFF AND SEPARATE LISTING OF MANDI INC. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED AND DECLARATION OF CONDITIONAL SPECIAL DIVIDEND BY WAY OF DISTRIBUTION IN SPECIE

  13. HKEXnews

    FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025

  14. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

  15. HKEXnews

    COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

  16. HKEXnews

    PLACING OF NEW SHARES UNDER GENERAL MANDATE

  17. HKEXnews

    PROPOSED SPIN-OFF AND SEPARATE LISTING OF MANDI INC. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED

  18. HKEXnews

    CONNECTED TRANSACTION GRANT OF AWARDED SHARES BY A SUBSIDIARY OF THE COMPANY PURSUANT TO ITS EQUITY INCENTIVE PLAN

  19. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025

  20. HKEXnews

    COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1530 on TradingView.

Listing details

3SBio, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1530, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
3SBio, Inc.
Ticker
1530
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
KYG8875G1029
Other listed symbols
GETTEX:83B; OTC:TRSBF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.